A study led by researchers at Baylor College of Medicine has uncovered a new strategy that can potentially treat age-related disease and decline.
The study, published in the journal Cell Metabolism, demonstrates that shortening of telomeres – the ends of the chromosomes – impairs a class of enzymes called sirtuins, which play an important role in maintaining cell fitness by affecting many metabolic processes and repairing damaged chromosomes. The researchers showed that restoring the activity of sirtuins with a small compound stabilized telomeres and reduced DNA damage, which in turn improved liver disease in a mouse model. These studies suggest that maintaining telomere length might help sustain the regenerative capacity of cells and tissues and improve disease outcome.
“Our genetic material is tightly packed into thread-like structures called chromosomes and at the ends of the chromosomes are particular pieces of DNA called telomeres. Telomeres work like the plastic tips at the end of shoelaces; they prevent chromosomes from unraveling or sticking to each other,” said Dr. Ergun Sahin, lead investigator and assistant professor in the Huffington Center on Aging and the Department of Molecular Physiology and Biophysics at Baylor.
Telomeres also are involved in aging and disease; as an organism gets older, telomeres shorten and cells progressively deteriorate, stop dividing and die. Telomere shortening during human aging is believed to be a major underlying cause of age-related decline of stem cells – cells with the potential to develop into many different types of cells and help in the healing process in the body. Telomere shortening also affects the susceptibility of tissues to disease; however, how telomere shortening impairs regeneration and increases risk of disease is not well understood. Evidence suggests that stabilizing telomeres could prevent or slow down aging and disease. In this study, Sahin and his colleagues investigated the effect of restoring telomere length in a mouse model of liver tissue fibrosis
Telomere shortening has been associated with increased risk of organ failure and tissue fibrosis, usually in liver and lung, as cells with compromised telomeres fail to divide to replace dying cells.
Previous studies have shown that both telomeres and sirtuins contribute to aging and tissue fibrosis and seemed to interact with each other. In this study, Sahin and his colleagues investigated the molecular mechanisms that connected telomeres and sirtuins. For this, they developed a mouse model of liver disease in which the animals were genetically engineered to develop shorter, dysfunctional telomeres and age prematurely. When exposed to certain compounds, these animals quickly develop liver fibrosis – scarring of the liver that over time can lead to cirrhosis.
“In these mice, we discovered that shorter telomeres triggered a reduction in the production of sirtuins in liver and other tissues as well,” Sahin said. “Telomere shortening signaled the cell to reduce the production of sirtuins. This observation indicates that telomeres regulate sirtuins.”
Interestingly, the researchers also found that in turn, sirtuins can affect telomeres. When Sahin and his colleagues increased the activity of sirtuins by feeding mice a small molecule – nicotinamide mono mononucleotide, or NMN, an NAD+ precursor – telomeres were stabilized.
“Furthermore, feeding NAD+ precursor to the mice not only maintained telomere length but also improved liver condition in these mice,” Sahin said.
More research is needed before these findings can be translated into treatments for human conditions.
“It’s important to keep in mind that telomere length can also affect cancer growth. Having shorter telomeres would set cancer cells on a path to self-destruction, but keeping their telomeres long would likely allow them to continue proliferating,” Sahin said. “We plan to continue our investigation on the molecular mechanisms involved in the telomere-sirtuin interactions in order to better understand the benefits as well as the potential risks of telomere length manipulation in health and disease.”
The Latest on: Age-related disease
[google_news title=”” keyword=”age-related disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Age-related disease
- Skin-Related Diseases Drive Demand for Medical Spa Services: Global Market Poised for Remarkable Growthon September 22, 2023 at 1:51 am
22, 2023 (GLOBE NEWSWIRE) -- The "Medical Spa Market by Service, by Age Group, and by Gender - Global Opportunity ... can be attributed to the increasing prevalence of skin-related diseases, ...
- Live long and prosperon September 21, 2023 at 11:36 pm
Hevolution — a portmanteau of health and evolution — will make grants to biotech firms, medical schools, and teaching hospitals working to slow aging and combat age-related disease.
- Differences between Alzheimer's and forgetfulness due to ageon September 21, 2023 at 4:45 am
How is Alzheimer’s different to age-related forgetfulness? NDTV has outlined seven ways that Alzheimer’s disease is different to age-related forgetfulness. While age-related forgetfulness is ...
- World Alzheimer's Day 2023: Here's How Alzheimer's Symptoms Are Different From Age-Related Forgetfulnesson September 20, 2023 at 4:57 am
World Alzheimer's Day is observed on September 21st every year. It is a day dedicated to raising awareness about Alzheimer's disease, a progressive neurological disorder that affects memory, thinking, ...
- Age-related drug companies, funds seek new life as boomers near 80on September 19, 2023 at 4:33 pm
Calico emerged, a second-generation of aging startups and investors (largely with tech backgrounds) are driving new ways to live longer and healthier — or reverse aging altogether ...
- What Is A Longevity Biotechnology Company?on September 16, 2023 at 3:34 am
You need to go after specific diseases to get the drug approved. Good news is that if the drug works in aging, it will work in some of the age-related diseases. But there are no quick hacks - you ...
- Selective removal of aging cells opens new possibilities for treating age-related diseaseson September 14, 2023 at 6:40 am
A research team, led by Professor Ja Hyoung Ryu from the Department of Chemistry at UNIST, in collaboration with Professor Hyewon Chung from Konkuk University, has achieved a significant breakthrough ...
- Visual Function and Mortality in Age-related Macular Degenerationon September 13, 2023 at 7:45 pm
Comorbidities associated with time to mortality included several of those mentioned earlier: diabetes, treated hypertension, kidney disease ... with neovascular age-related macular degeneration ...
- Age-Related Macular Degeneration: Circulating Metabolites, Genetics, and Lifestyleon September 13, 2023 at 7:45 pm
2 Consequently, high-throughput analysis of metabolites (metabolomics) can provide evidence of disease pathways ... in patients with neovascular age-related macular degeneration undergoing ...
- From hagfish to membrane: Modeling age-related macular degenerationon September 13, 2023 at 5:19 pm
Researchers have successfully demonstrated that hagfish slime proteins can accurately replicate membranes in the human eye. Scientists were able to properly grow retinal cells on hagfish slime ...
via Bing News